...
首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Immune tolerance of mice allogenic tooth transplantation induced by immature dendritic cells
【24h】

Immune tolerance of mice allogenic tooth transplantation induced by immature dendritic cells

机译:未成熟树突状细胞诱导小鼠异体牙移植的免疫耐受性

获取原文
           

摘要

As a common procedure in dentistry for replacing a missing tooth, allogenic tooth transplantation has encountered many difficulties in the clinical application because of immunological rejection. It is hypothesized that immature dendritic cell injection might be a potential alternative method to avoid or alleviate immunological rejection in allogenic tooth transplantation. To test this hypothesis, a mouse model of allogenic and autogeneic tooth transplantation was to established test the immunosuppressive effect of immature dendritic cells (imDCs) derived from donor bone marrows on transplant rejection in allogenic tooth transplantation. 2 × 10sup6/sup imDCs generated with 50 U/ml GM-CSF were injected to each recipient mouse by two ways: tail vein injection 7 days before transplantation or regional dermal injection at day 0 and day 3 after transplantation. Groups of autogeneic tooth transplantation and allogenic tooth transplantation without any treatment were set as control groups. The effects were evaluated with histopathology and immunohistochemistry. We found there was no obvious rejection in autogeneic tooth transplantation group; tail intravenous injection group showed obviously alleviated rejection while local injection group and none-treatment allogenic tooth transplantation group both showed severe rejection. Our results suggested that the rejection of allogenic tooth transplantation could be alleviated by tail vein injection of donor bone marrow-derived imDCs though it could not be completely eliminated. The clinical application of imDCs in allogenic tooth transplantation still needs further deep research.
机译:作为牙科中缺失牙的常见手术,由于免疫排斥反应,异体牙移植在临床应用中遇到了许多困难。据推测,未成熟的树突状细胞注射可能是避免或减轻异体牙齿移植中免疫排斥反应的潜在替代方法。为了检验该假设,建立了同种异体和自体牙齿移植的小鼠模型,以测试源自供体骨髓的未成熟树突状细胞(imDCs)对异体牙移植中移植排斥的免疫抑制作用。 2×通过两种方式将50 U / ml GM-CSF生成的10 6 imDCs注入每只受体小鼠:移植前7天进行尾静脉注射或移植后第0天和第3天进行局部皮肤注射。将未经任何处理的自体牙移植和同种异体牙移植组作为对照组。通过组织病理学和免疫组织化学评估效果。我们发现自体牙齿移植组没有明显的排斥反应。尾静脉注射组排斥反应明显减轻,局部注射组和异体牙移植未治疗组均出现严重排斥反应。我们的研究结果表明,尽管不能完全消除异体牙齿移植的排斥反应,但可以通过尾静脉注射供体骨髓来源的imDCs来缓解。 imDCs在异体牙移植中的临床应用仍需进一步深入研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号